MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 20,807 shares, a decline of 42.2% from the April 15th total of 36,003 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 2,603,967 shares, the days-to-cover ratio is presently 0.0 days.
MariMed Stock Up 7.4%
Shares of MRMD opened at $0.07 on Tuesday. The company has a market capitalization of $28.54 million, a PE ratio of -2.38 and a beta of 1.33. MariMed has a 12 month low of $0.06 and a 12 month high of $0.23. The stock’s 50-day moving average price is $0.08 and its two-hundred day moving average price is $0.09. The company has a current ratio of 0.95, a quick ratio of 0.34 and a debt-to-equity ratio of 1.67.
MariMed (OTCMKTS:MRMD – Get Free Report) last announced its earnings results on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The firm had revenue of $39.48 million for the quarter, compared to the consensus estimate of $38.75 million. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%. On average, analysts anticipate that MariMed will post -0.05 EPS for the current year.
About MariMed
MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.
The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.
Read More
- Five stocks we like better than MariMed
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
